Insulet | PODD - Ebit

Stock Price
251.19
Daily Change
-5.43 -2.12%
Monthly
-11.40%
Yearly
-9.80%
Q1 Forecast
247.93

Insulet reported $117.7M in EBIT for its fiscal quarter ending in September of 2025.





Ebit Change Date
Abbott USD 2.54B 358M Dec/2025
Align Technology USD 184.65M 21.61M Sep/2025
AtriCure USD 208K 4.03M Sep/2025
Avanos Medical USD 18.97M 72.63M Sep/2025
Baxter International USD 201.2M 70.8M Sep/2025
Becton, Dickinson and Co. USD 826M 153M Sep/2025
Boston Scientific USD 1.04B 98M Sep/2025
Cardinal Health USD 754M 125M Sep/2025
Cooper Companies USD 140.4M 35.3M Sep/2025
Dexcom USD 242.5M 3.3M Sep/2025
Edwards Lifesciences USD 425.1M 5.8M Sep/2025
Eli Lilly USD 7.02B 3.32B Jun/2025
Globus Medical USD -117.52M 8.43M Sep/2025
ICU Medical USD 26.86M 52K Sep/2025
Insulet USD 117.7M 3.4M Sep/2025
Integra LifeSciences USD 11.76M 521.67M Sep/2025
J&J USD 5.11B 2.3B Dec/2025
Masimo USD 83.7M 19.2M Sep/2025
Medtronic USD 1.7B 100M Sep/2025
Merit Medical Systems USD 42.61M 7.54M Sep/2025
Roche Holding CHF 9.56B 2.1B Dec/2025
Solventum Corp USD 1.69B 1.47B Sep/2025
Stryker USD 1.97B 609M Dec/2025
Tandem Diabetes Care USD -22.86M 9M Sep/2025
Teleflex USD 112.65M 44.3M Sep/2025
West Pharmaceutical Services USD 167.6M 13.9M Sep/2025
Zimmer Biomet Holdings USD 338.3M 58.1M Sep/2025